LIGAND PHARMACEUTICALS (LGND) Stock Ownership and Short Interest
USA - NASDAQ:LGND - US53220K5048 - Common Stock
185.25 USD
-0.32 (-0.17%)
185.25 USD
0 (0%)
| Shares Outstanding | 19.60M |
| Float | 19.15M |
| Float Short Interest Percentage | 5.86% |
| Owners (insider) | 1.69% |
| Owners (institutional) | 100.32% |
| Owners (insider) change | 0.43% |
| Owners (institutional) change | -0.28% |
Insider Transactions
Top Institutional Holders
Insider Owners
| Date | Name | Type | Shares | Price | Amount |
|---|---|---|---|---|---|
| Oct 1, 2025 | KOZARICH JOHN W | Open Market Sale | 467 | 179.44 | $ 83,800.34 |
| Sep 23, 2025 | Aryeh Jason | Open Market Sale | 10000 | 170.81 | $ 1,708,087.72 |
| Sep 22, 2025 | Zimmermann Martine | Option Excercise | 115 | 170.77 | $ 19,638.55 |
| Sep 2, 2025 | KOZARICH JOHN W | Open Market Sale | 467 | 162.26 | $ 75,774.85 |
| Aug 10, 2025 | Reardon Andrew | Option Excercise | 1325 | 150.06 | $ 198,829.50 |
| Aug 1, 2025 | KOZARICH JOHN W | Open Market Sale | 467 | 131.88 | $ 61,585.86 |
| Jul 10, 2025 | KOZARICH JOHN W | Open Market Sale | 934 | 125.00 | $ 116,750.00 |
| Jun 30, 2025 | Reardon Andrew | Other Aquisition | 233 | 91.08 | $ 21,221.06 |
| Jun 30, 2025 | Espinoza Octavio | Other Aquisition | 224 | 91.08 | $ 20,401.36 |
| Jun 30, 2025 | Davis Todd C | Other Aquisition | 233 | 91.08 | $ 21,221.06 |
| Jun 23, 2025 | Reardon Andrew | Open Market Sale | 500 | 114.08 | $ 57,042.15 |
| Jun 10, 2025 | Reardon Andrew | Open Market Sale | 500 | 114.54 | $ 57,270.70 |
| Jun 6, 2025 | LAMATTINA JOHN L | Grant | 1209 | 0.00 | $ 0.00 |
| Jun 6, 2025 | Zimmermann Martine | Grant | 1209 | 0.00 | $ 0.00 |
| Jun 6, 2025 | Zimmermann Martine | Option Excercise | 188 | 105.99 | $ 19,926.12 |
| Jun 6, 2025 | Sabba Stephen L | Grant | 1209 | 0.00 | $ 0.00 |
| Jun 6, 2025 | KOZARICH JOHN W | Grant | 1209 | 0.00 | $ 0.00 |
| Jun 6, 2025 | Haas Jason | Grant | 1209 | 0.00 | $ 0.00 |
| Jun 6, 2025 | Aryeh Jason | Grant | 1209 | 0.00 | $ 0.00 |
| Jun 6, 2025 | Gray Nancy Ryan | Grant | 1209 | 0.00 | $ 0.00 |
| May 9, 2025 | Davis Todd C | Open Market Purchase | 9510 | 105.20 | $ 1,000,456.37 |
| May 9, 2025 | Espinoza Octavio | Open Market Purchase | 1500 | 104.06 | $ 156,090.00 |
| Mar 4, 2025 | Espinoza Octavio | Open Market Sale | 5000 | 115.03 | $ 575,148.50 |
| Mar 4, 2025 | Espinoza Octavio | Grant | 7484 | 0.00 | $ 0.00 |
| Mar 4, 2025 | Davis Todd C | Grant | 21382 | 0.00 | $ 0.00 |
| Mar 4, 2025 | Reardon Andrew | Grant | 6415 | 0.00 | $ 0.00 |
| Feb 14, 2025 | Reardon Andrew | Grant | 12357 | 0.00 | $ 0.00 |
| Feb 14, 2025 | Reardon Andrew | Option Excercise | 6523 | 120.00 | $ 782,760.00 |
| Feb 14, 2025 | Davis Todd C | Grant | 20784 | 0.00 | $ 0.00 |
| Feb 14, 2025 | Davis Todd C | Option Excercise | 13452 | 120.00 | $ 1,614,240.00 |
| Feb 14, 2025 | Espinoza Octavio | Grant | 12819 | 0.00 | $ 0.00 |
| Feb 14, 2025 | Espinoza Octavio | Option Excercise | 9587 | 120.00 | $ 1,150,440.00 |
| Dec 23, 2024 | Espinoza Octavio | Open Market Sale | 2104 | 116.37 | $ 244,850.48 |
| Dec 5, 2024 | Espinoza Octavio | Option Excercise | 1859 | 123.51 | $ 229,605.09 |
| Nov 27, 2024 | LAMATTINA JOHN L | Option Excercise | 2406 | 52.30 | $ 125,833.80 |
| Nov 27, 2024 | LAMATTINA JOHN L | Open Market Sale | 2406 | 123.65 | $ 297,501.90 |